Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/11/23 → 11/11/25 |
Keywords
- clinical trial
- Metastatic Cancer
- immunotherapy
- PD-1
Clinical Trial Phase
- Phase I
- Phase II
A Phase 1/2, First-in-human, Open-label Study of Single-agent AWT020 in Patients with Progressive Locally Advanced or Metastatic Cancer
- Voskoboynik, Mark (Primary Chief Investigator (PCI))
- Frentzas, Sophia (Partner Investigator (PI))
Project: Research